USE OF HIGH POTENCY STATINS FOR PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: PRACTICE IMPACT OF THE NEW CHOLESTEROL GUIDELINES

被引：0
|
作者：
Rodriguez, Fatima [1 ]
Heidenreich, Paul [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)61436-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-104
引用
收藏
页码：A1436 / A1436
页数：1
相关论文
共 50 条
  • [41] New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
    Hu Da-Yi
    慢性疾病与转化医学（英文）, 2017, 3 (02) : 73 - 74
  • [42] Understanding the new atherosclerotic cardiovascular disease prevention guidelines: going beyond the headlines
    Stone, Neil J.
    Lloyd-Jones, Donald M.
    CLINICAL LIPIDOLOGY, 2014, 9 (02) : 121 - 123
  • [43] The Role of HDL Cholesterol in Patients With Atherosclerotic Cardiovascular Disease Under Statin Treatment
    Yi-Heng, Li
    Yin, Wei-Hsian
    Tseng, Wei-Kung
    Lin, Fang-Ju
    Wu, Yen-Wen
    Hsieh, I-Chang
    Lin, Tsung-Hsien
    Sheu, Huey-Herng
    Yeh, Hung-, I
    Chen, Jaw-Wen
    Wu, Chau-Chung
    CIRCULATION, 2018, 138
  • [44] Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
    Okerson, Ted
    Patel, Jeetvan
    DiMario, Stefan
    Burton, Tanya
    Seare, Jerald
    Harrison, David J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (03):
  • [45] New European guidelines for cardiovascular disease prevention in clinical practice
    De Backer, Guy
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (02) : 138 - 142
  • [46] Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease (vol 231, pg 36, 2021)
    Shavadia, Jay S.
    Wilson, Jonathan
    Edmonston, Daniel
    Platt, Alyssa
    Ephraim, Patti
    Hall, Rasheeda
    Goldstein, Benjamin A.
    Boulware, L. Ebony
    Peterson, Eric
    Pendergast, Jane
    Scialla, Julia J.
    AMERICAN HEART JOURNAL, 2022, 253 : 99 - 100
  • [47] Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
    Schonberger, Robert B.
    Vallurupalli, Vivek
    Matlin, Hollie
    Blitz, Daina
    Nwozuzu, Adambeke
    Barron, Brian
    Zhang, Yuemei
    Dai, Feng
    Jacoby, Daniel
    Nasir, Khurram
    Bardia, Amit
    PREVENTIVE MEDICINE REPORTS, 2020, 18
  • [48] Is Myopathy the Achilles' Heel of Statins? Differences Between the New Cholesterol Treatment Guidelines and Everyday Clinical Practice
    Rallidis, Loukianos S.
    Anastasiou-Nana, Maria
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (21) : 2300 - 2301
  • [49] The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease
    Drexel, Heinz
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Heinzle, Christine F.
    Moser, Berthold
    Zanolin-Purin, Daniela
    Saely, Christoph H.
    ATHEROSCLEROSIS, 2021, 329 : 44 - 49
  • [50] Distribution of Remnant Cholesterol in Patients with Type 2 Diabetes and in Nondiabetic Patients with Established Cardiovascular Disease
    Drexel, Heinz
    Plattner, Thomas
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Saely, Christoph H.
    DIABETES, 2024, 73
12345